title: Effects of stability on the biological function of p53.
abstract: The core domain of the tumor suppressor p53 has low thermodynamic stability, and many oncogenic mutations cause it to denature rapidly at body temperature. We made a series of core domain mutants that are significantly less or more stable than wild type to investigate effects of stability on the transcriptional activity and levels of native full-length p53 in H1299 mammalian cells. The levels of transcriptionally inactive native protein with inactivating mutations in the N-terminal transactivation domain correlated strongly with stability. The levels of transcriptionally active proteins, however, depended on both their stability and the transcriptional activity that leads to the feedback loop of proteolytic degradation via transcription of E3 ligases. A very highly stabilized quadruple mutant and an even more stable hexamutant were more active than wild-type p53 in terms of Bax transcription and apoptotic activity, and reached higher levels than wild type in cells. The increased activity did not result from increased overall stability but was due to a single known suppressor mutation, N239Y. It is possible that the low intrinsic stability of p53 is a means of keeping its level low in the cell by spontaneous denaturation, by a route additional to that of proteolytic degradation via E3 ligase pathways. Denatured p53 does accumulate in cells, and there are pathways for the proteolysis of denatured proteins.
authors.affiliation: Medical Research Council Centre for Protein Engineering, Cambridge CB2 0QH, United Kingdom.
authors.forename: Kian Hoe
authors.initials: KH
authors.lastname: Khoo
authors.forename: Sebastian
authors.initials: S
authors.lastname: Mayer
authors.forename: Alan R
authors.initials: AR
authors.lastname: Fersht
mesh_terms: D002460:Cell Line; D002470:Cell Survival; D006801:Humans; D009154:Mutation; D055550:Protein Stability; D017434:Protein Structure, Tertiary; D014158:Transcription, Genetic; D015533:Transcriptional Activation; D016159:Tumor Suppressor Protein p53 / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*
chemical_list: D016159:Tumor Suppressor Protein p53
references.citation: Mol Cell. 2006 Jul 21;23(2):251-63
references.pmid: 16857591
references.citation: Biochemistry. 2008 Mar 11;47(10):3235-44
references.pmid: 18260640
references.citation: Proc Natl Acad Sci U S A. 2008 Apr 15;105(15):5762-7
references.pmid: 18391200
references.citation: Protein Eng Des Sel. 2009 Jul;22(7):421-30
references.pmid: 19515728
references.citation: Oncogene. 2000 Mar 2;19(10):1245-56
references.pmid: 10713666
references.citation: J Biol Chem. 2004 Jan 9;279(2):1291-6
references.pmid: 14534297
references.citation: Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2109-14
references.pmid: 16461916
references.citation: EMBO J. 2000 Feb 1;19(3):370-8
references.pmid: 10654936
references.citation: Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13303-7
references.pmid: 14595027
references.citation: Nature. 1997 May 15;387(6630):299-303
references.pmid: 9153396
references.citation: Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14338-42
references.pmid: 9405613
references.citation: Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14675-80
references.pmid: 9843948
references.citation: J Neurochem. 2002 Oct;83(1):176-85
references.pmid: 12358741
references.citation: J Biol Chem. 1998 May 22;273(21):13030-6
references.pmid: 9582339
references.citation: Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15056-61
references.pmid: 17015838
references.citation: J Mol Biol. 2007 Sep 7;372(1):268-76
references.pmid: 17631895
references.citation: J Biol Chem. 2003 Jun 27;278(26):24108-12
references.pmid: 12700230
references.citation: Hum Mutat. 2002 Jun;19(6):607-14
references.pmid: 12007217
references.citation: EMBO J. 1998 Apr 1;17(7):1847-59
references.pmid: 9524109
references.citation: Science. 2003 Jan 17;299(5605):408-11
references.pmid: 12481023
references.citation: Oncogene. 1997 Aug 14;15(7):807-16
references.pmid: 9266967
references.citation: Cell Cycle. 2005 Aug;4(8):1015-8
references.pmid: 16082197
references.citation: J Biol Chem. 2006 Aug 4;281(31):21934-21941
references.pmid: 16754663
references.citation: Physiol Rev. 2002 Apr;82(2):373-428
references.pmid: 11917093
references.citation: J Cell Sci. 2000 May;113 ( Pt 10):1661-70
references.pmid: 10769197
references.citation: Genes Dev. 1993 Jul;7(7A):1126-32
references.pmid: 8319905
references.citation: Cell. 2003 Mar 21;112(6):779-91
references.pmid: 12654245
references.citation: Cell Death Differ. 2010 Jan;17(1):93-102
references.pmid: 19498444
references.citation: Mol Cell Biol. 2006 Mar;26(6):2297-308
references.pmid: 16508005
references.citation: Oncogene. 1999 Apr 8;18(14):2405-10
references.pmid: 10327062
references.citation: Curr Opin Cell Biol. 2003 Apr;15(2):164-71
references.pmid: 12648672
references.citation: EMBO J. 1993 Feb;12(2):461-8
references.pmid: 8440237
references.citation: J Mol Biol. 1999 Jan 29;285(4):1869-86
references.pmid: 9917418
references.citation: Proc Natl Acad Sci U S A. 2007 Jul 24;104(30):12324-9
references.pmid: 17620598
references.citation: J Biol Chem. 2001 Oct 5;276(40):37390-401
references.pmid: 11477076
references.citation: Nat Biotechnol. 1999 Jul;17(7):691-5
references.pmid: 10404163
references.citation: EMBO J. 1994 Jun 1;13(11):2535-44
references.pmid: 8013454
references.citation: Nature. 2004 May 6;429(6987):86-92
references.pmid: 15103385
references.citation: Nature. 2000 Nov 16;408(6810):307-10
references.pmid: 11099028
references.citation: Nat Rev Cancer. 2001 Oct;1(1):68-76
references.pmid: 11900253
references.citation: Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1227-32
references.pmid: 16432196
references.citation: Annu Rev Biochem. 2008;77:557-82
references.pmid: 18410249
references.citation: Nat Rev Cancer. 2006 Dec;6(12):909-23
references.pmid: 17128209